Home > Boards > US Listed > Medical - Healthcare > Genprex Inc (GNPX)

Classic bullshit from our amigo Zride fake Pushing

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Barrario Member Profile
 
Followed By 13
Posts 3,326
Boards Moderated 0
Alias Born 02/21/16
160x600 placeholder
Genprex in-licenses additional gene therapy technologies for treatment of lung cancer Seeking Alpha - 5/6/2021 9:31:54 AM
Genprex In-Licenses Additional Gene Therapy Technologies for Treatment of Lung Cancer Business Wire - 5/6/2021 9:05:00 AM
Genprex receives IRB approval for NSCLC gene therapy trial; shares up 4% Seeking Alpha - 5/5/2021 9:21:10 AM
Genprex Announces Centralized Institutional Review Board Approval for Acclaim-1 Clinical Trial in Non-Small Cell Lung Cancer Business Wire - 5/5/2021 8:55:00 AM
Genprex Initiates Site Recruitment for Acclaim-2 Clinical Trial for the Treatment of Non-Small Cell Lung Cancer Business Wire - 5/4/2021 9:32:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/30/2021 4:14:32 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2021 4:14:20 PM
Genprex to Participate in CEO Roadshow Webinar Series Business Wire - 4/21/2021 8:30:00 AM
Genprex to Receive Inaugural “License of the Year” Award from University of Pittsburgh Innovation Institute in Recognitio... Business Wire - 4/20/2021 8:30:00 AM
Genprex's Reqorsa combo shows encouraging activity in lung cancer, shares up 3% Seeking Alpha - 4/12/2021 8:54:18 AM
Genprex Collaborators Report Positive Preclinical Data for REQORSA™ Immunogene Therapy in Non-Small Cell Lung Cancer at the... Business Wire - 4/12/2021 8:30:00 AM
Auris Medical, Prometheus Biosciences leads healthcare gainers; Endo International, Odonate Therapeutics among major losers Seeking Alpha - 4/8/2021 11:05:06 AM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 4/7/2021 4:38:36 PM
Genprex to Present at the 2021 Virtual Cell & Gene Meeting on the Mediterranean Business Wire - 4/5/2021 8:30:00 AM
Genprex Announces Preclinical Data for TUSC2 Immunogene Therapy in Non-Small Cell Lung Cancer to Be Featured in Two Presentat... Business Wire - 3/30/2021 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/25/2021 7:06:19 PM
Genprex to Present at the Spring 2021 Oncology Investor Conference on March 29 Business Wire - 3/24/2021 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/23/2021 4:49:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/23/2021 4:49:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/23/2021 4:47:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/9/2021 9:07:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/2/2021 4:45:40 PM
Genprex to Participate in Upcoming March Investor Conferences Business Wire - 3/1/2021 8:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/19/2021 1:09:56 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 9:47:19 AM
Barrario   Friday, 08/14/20 03:43:45 PM
Re: None
Post # of 3752 
Classic bullshit from our amigo Zride fake

Pushing luck with four days of green . Correction on deck. Might be a good idea this time to take some profit before exits get too crowded. When this thing goes up whether or not on news or no (FNMA) news it will always pullback .
Back below $2 by Wednesday.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences